reported that Aifm3 can be applied as a prognostic bio‐indicator for breast cancer patients.[48] Our research has shown that Aifm3 knockdown results in impaired neurogenesis and oxidative state of the NPCs and indicated that Aifm3 interacts with Ndufa9, a component of complex I, in the electron transport chain of the inner mitochondrial membrane, disrupts the electron transport chain and inhibits the TCA cycle, which in turn inhibits oxidative phosphorylation. The gene discussed is NDUFA9; the disease is breast carcinoma.